首页 | 本学科首页   官方微博 | 高级检索  
     

单唾液酸四己糖神经节苷酯治疗新生儿缺氧缺血性脑病90例
引用本文:郑磊,邵斌,任艳丽,胡生海. 单唾液酸四己糖神经节苷酯治疗新生儿缺氧缺血性脑病90例[J]. 中国实用神经疾病杂志, 2008, 11(7): 54-55
作者姓名:郑磊  邵斌  任艳丽  胡生海
作者单位:郑州大学第三附属医院药剂科,郑州,450052;郑州大学第三附属医院药剂科,郑州,450052;郑州大学第三附属医院药剂科,郑州,450052;郑州大学第三附属医院药剂科,郑州,450052
摘    要:
目的研究单唾液酸四己糖神经节苷酯(GM1)静滴治疗新生儿缺氧缺血性脑病(HIE)疗效。方法将90例HIE患儿随机分为观察组和对照组,每组45例,均予常规治疗,观察组加用GM1。观察和记录2组临床症状、体征恢复情况和新生儿行为神经测定(NBNA)评分。结果应用GM1治疗新生儿HIE对改善HIE所致的远期神经系统发育障碍有较好的疗效。结论在常规治疗基础上加用GM1是目前治疗中重度HIE较理想的方法。

关 键 词:新生儿缺氧缺血性脑病  单唾液酸四己糖神经节苷酯  疗效观察

Evaluation of clinical effect of neonatal hypoxic-ischemic encephalopathy on 90 cases of monosialoganglioside
Zheng Lei,Shao Bin,Ren Yanli,et al.. Evaluation of clinical effect of neonatal hypoxic-ischemic encephalopathy on 90 cases of monosialoganglioside[J]. Chinese Journal of Practical Neruous Diseases, 2008, 11(7): 54-55
Authors:Zheng Lei  Shao Bin  Ren Yanli  et al.
Affiliation:Zheng Lei,Shao Bin,Ren Yanli,et al.Department of Pharmacy,the Third Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China
Abstract:
Objective To investigate the therapeutic effect of monosialoganglioside(GM1) treating neonatal hypoxic-ischemic encephalopathy(HIE).Methods 90 cases of patients with HIE were divided into experimental group(n= 45) and routine treatment group(n= 45) randomly.Patients in pidotimod group were given additional treatment of monosialoganglioside on the basis of routine treatment.Clinical symptoms,status of physical signs recovery and neonatal behavioral neurological assessment(NBNA) were observed and recorded.Results Monosialoganglioside had better curative effect on the neurodevelopmental impairment and disability caused by HIE.Conclusion Given additional treatment of monosialoganglioside on the basis of routine treatment is a desirable way to therapy moderate or severe HIE.
Keywords:Neonatal hypoxic-ischemic encephalopathy  Monosialoganglioside  Observation of curative effect
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号